Dupilumab: Una revisión de su potencial en el tratamiento de la rinosinusitis crónica con poliposis nasal (RSCPN)

Sree sudha, TY; Pugazhenthan, T; Krishna sasanka, KSBS; Sri Hari, TY; vijayakumar, AR

Chronic rhino sinusitis with nasal polyps (CRSwNP) is a chronic inflammatory condition of the sinuses, commonly seen in between 40-60 years aged population. In CRSwNP patients the main focus of treatment is to promote patient’s quality of life, to reduce sinonasal symptoms and nasal polyp size by usage of both oral as well as topical corticosteroids and nasal saline irrigations. If symptoms persists after using medical therapy surgical excision is the last option but relapse of disease is present in most cases even after surgical intervention. Overall, from the various recent past and recent trials, Dupilumab was very well tolerated in maximum number of the patients and no serious adverse events were noted. In addition the patients with asthma noticed good improvement in endoscopic nasal polyp scores, asthma control, and lung function, inflammation of both the upper and lower airways.